Is TBP.TO undervalued or overvalued?
As of 2025-04-18, the Intrinsic Value of Tetra Bio Pharma Inc (TBP.TO) is -0.46 CAD. This TBP.TO valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.03 CAD, the upside of Tetra Bio Pharma Inc is -1,943.23%. This means that TBP.TO is overvalued by 1,943.23%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
Range | Selected | Upside | |
a | |||
Fair Value | -0.46 - -0.46 | -0.46 | -1,943.23% |
P/E | (0.45) - (0.86) | (0.47) | -1961.7% |
DDM - Stable | (0.81) - (3.39) | (2.10) | -8517.2% |
DDM - Multi | (1.03) - (3.39) | (1.58) | -6432.2% |
Market Cap (mil) | 10.58 |
Beta | 1.87 |
Outstanding shares (mil) | 423.36 |
Enterprise Value (mil) | 11.76 |
Market risk premium | 5.50% |
Cost of Equity | 9.18% |
Cost of Debt | 5.00% |
WACC | 7.94% |